Union Bancaire Privee, Ubp Sa Ocular Therapeutix, Inc Transaction History
Union Bancaire Privee, Ubp Sa
- $6.72 Billion
- Q4 2025
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 22,000 shares of OCUL stock, worth $250,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,000
Previous 25,500
13.73%
Holding current value
$250,139
Previous $298,000
16.11%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
236Shares Held
158MCall Options Held
1.24MPut Options Held
423K-
Vr Adviser, LLC New York, NY13.2MShares$150 Million23.37% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$143 Million98.91% of portfolio
-
Deep Track Capital, LP Greenwich, CT11.9MShares$136 Million4.4% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$131 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.3MShares$117 Million1.64% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $875M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...